Drugs / Heliox21
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01498432 | Jan 2012 → Jan 2013 | respiratory failure | University College, London | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Heliox21 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01498432 ↗ |
| Route | Other | “Heliox21 has generally been administered through a simple face-mask (+/- rebreathing bag)” NCT01498432 ↗ |